Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - ia1xxx
6
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Auscultatory Training System and Telemedicine Tool with Accurate Reproduction of Physiological Sounds
This CDC developed auscultatory training apparatus includes a database of prerecorded physiological sounds (e.g., lung, bowel, or heart sounds) stored on a computer for playback. Current teaching tools, which utilize previously recorded sounds, suffer from the disadvantage that playback environments cause considerable distortion and errors in sound...
Published: 10/28/2024
|
Inventor(s):
Jeffrey Reynolds
,
Kimberly Friend
,
William Goldsmith
,
David Frazer
,
Walter McKinney
Keywords(s):
AA3B6X
,
AA3BXX
,
AA3XXX
,
AAXXXX
,
AB4XXX
,
ACXXXX
,
ADXXXX
,
AFXXXX
,
Auscultatory
,
AXXXXX
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
IA1XXX
,
IA5XXX
,
IAXXXX
,
IB1FXX
,
IB4XXX
,
ICXXXX
,
IDXXXX
,
IXXXXX
,
NIOSH-HELD
,
System
,
TRAINING
,
VDXXXX
,
VOXXXX
,
VPXXXX
,
WBXXXX
,
WFXXXX
,
WHXXXX
,
WIXXXX
,
WMXXXX
,
XDXXXX
,
XFXXXX
,
XIXXXX
,
XJXXXX
,
YEXXXX
,
YFXXXX
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Endocrinology
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Cardiology
,
ResearchProducts > Computational models/software
,
Application > Non-Medical Devices
,
Application > Consumer Products
,
TherapeuticArea > Dental
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Oncology
,
Application > Software / Apps
,
Application > Occupational Safety and Health
,
Application > Medical Devices
,
TherapeuticArea > Pulmonology
,
Application > Research Materials
,
Application > Diagnostics
Glucocerebrosidase Activators as a Treatment for Gaucher Disease
This technology is a collection of small molecule activators of a genetically defective version of the enzyme called glucocerebrosidase (GCase), which causes Gaucher disease. Gaucher disease is a rare disease affecting 1 in 40,000 babies born. Ashkenazi Jews of eastern European descent (about 1 in 800 live births) are at particular risk of carrying...
Published: 10/28/2024
|
Inventor(s):
Noel Southall
,
Ehud Goldin
,
Wei Zheng
,
Samarjit Patnaik
,
Ellen Sidransky
,
Omid Motabar
,
Wendy Westbroek
,
Juan Marugan
Keywords(s):
ACTIVATORS
,
Disease
,
Gaucher
,
GLUCOCEREBROSIDASE
,
IA1AXX
,
IA1XXX
,
IAXXXX
,
IB6XXX
,
IBXXXX
,
IXXXXX
,
treatment
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Reproductive Health
,
Application > Research Materials
,
Application > Diagnostics
,
Application > Therapeutics
,
Application > Vaccines
,
TherapeuticArea > Cardiology
Selective 12-Human Lipoxygenase Inhibitors for the Treatment of Diabetes and Clotting
This invention discloses small molecule inhibitors of human 12-lipoxygenase (12-hLO). 12-lipoxygenase expression, activation, and lipid metabolites have been implicated in type 1 and type 2 diabetes, cardiovascular disease, hypertension, Alzheimer’s, and Parkinson’s disease. The development of 12-hLO inhibitors may be a potent intracellular approach...
Published: 10/28/2024
|
Inventor(s):
Jerry Nadler
,
Michael Holinstat
,
Anton Simeonov
,
Ajit Jadhav
,
Theodore Holman
,
David Maloney
Keywords(s):
12-human
,
Cardiovascular
,
CAUSED
,
Clot
,
DIABETES
,
Discovery
,
Disease
,
Formation
,
IA1AXX
,
IA1XXX
,
IAXXXX
,
Inhibitors
,
IXXXXX
,
LIPOXYGENASE
,
Platelet-mediated
,
Prevention
,
SELECTIVE
,
treatment
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
TherapeuticArea > Cardiology
,
Application > Therapeutics
,
Application > Diagnostics
Farnesyltransferase Inhibitors for Treatment of Laminopathies, Cellular Aging and Atherosclerosis
Hutchinson-Gilford Progeria Syndrome (HGPS) is a very rare progressive childhood disorder characterized by premature aging (progeria). Recently, the gene responsible for HGPS was identified (Eriksson M, et al. Nature 2003), and HGPS joined a group of syndromes — the laminopathies — all of which are caused by various mutations in the lamin A/C gene...
Published: 10/28/2024
|
Inventor(s):
Francis Collins
Keywords(s):
(4)r syndrome
,
AA5XXX
,
AAXXXX
,
AXXXXX
,
C syndrome
,
Chromosome 4 ring syndrome
,
Chromosome 6 ring syndrome
,
Chromosome 7 ring syndrome
,
G syndrome
,
Hutchinson Gilford Syndrome
,
Hypertelorism with esophageal abnormality and hypospadias
,
IA1XXX
,
IAXXXX
,
IXXXXX
,
N syndrome
,
Premature aging
,
Progeria
,
Progeria; Hutchinson-Gilford progeria syndrome
,
R(6) syndrome
,
R(7) syndrome
,
Syndrome X
,
W syndrome
,
W syndrome; Syndrome W
Category(s):
Collaboration Sought > Licensing
,
Application > Diagnostics
,
Application > Research Materials
,
TherapeuticArea > Cardiology
,
Application > Therapeutics
Methods for Diagnosis of Atherosclerosis
The identification of more sensitive and specific markers of atherosclerosis that are non-invasive and cost-effective may have profound impacts on public health. One such strategy involves the detection of marker genes or their products in blood or serum. Such markers may help identify high-risk patients with subclinical atherosclerosis who may benefit...
Published: 10/28/2024
|
Inventor(s):
Paul Hwang
Keywords(s):
ATHEROSCLEROSIS
,
FOS
,
IA1XXX
,
IAXXXX
,
IXXXXX
,
MARKER
,
Novel
,
Patent Category - Biotechnology
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Cardiology
,
Application > Therapeutics
,
Application > Research Materials
,
Application > Diagnostics
ApoA-1 Mimetic Peptides Promoting Lipid Efflux from Cells for Treatment of Vascular Disorders
This invention involves ApoA-1 mimetic peptides with multiple amphipathic alpha-helical domains that promote lipid efflux from cells and are useful in the treatment and prevention of dyslipidemic, inflammatory and vascular disorders. IND-enabling studies for one of the peptides, named Fx-5A, are completed in preparation for an IND filing at the FDA,...
Published: 10/28/2024
|
Inventor(s):
Edward Neufeld
,
Fairwell Thomas
,
H. Bryan Brewer
,
Stephen Demosky
,
John Stonik
,
Marcelo Amar
,
Alan Remaley
Keywords(s):
(4)r syndrome
,
3-@hydroxyacyl-coa dehydrogenase deficiency
,
AMPHIPATHIC
,
assay
,
Atherosclerosis.
,
C syndrome
,
Chromosome 4 ring syndrome
,
Chromosome 6 ring syndrome
,
Chromosome 7 ring syndrome
,
COMPOSITION
,
G syndrome
,
HAD deficiency
,
HELICAL
,
HIS deficiency
,
Histidinemia
,
Hyperlipoproteinemia
,
Hypertelorism with esophageal abnormality and hypospadias
,
IA1XXX
,
IAXXXX
,
IXXXXX
,
Listed LPM Nguyen-Antczak as of 4/15/2015
,
Multi-domain
,
N syndrome
,
Patent Category - Biotechnology
,
Peptides
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
R(6) syndrome
,
R(7) syndrome
,
Syndrome X
,
System
,
treatment
,
UA1XXX
,
VDXXXX
,
VHXXXX
,
W syndrome
,
W syndrome; Syndrome W
,
WJXXXX
,
YAXXXX
,
YBXXXX
,
YCXXXX
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Endocrinology
,
Application > Therapeutics
,
TherapeuticArea > Rare / Neglected Diseases
,
Application > Research Materials
,
Application > Diagnostics